2024 Q2 Form 10-Q Financial Statement

#000121390024051214 Filed on June 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $707.0K $313.9K $258.4K
YoY Change 51.0% -49.48%
Cost Of Revenue $351.7K $173.2K $131.7K
YoY Change -2.29%
Gross Profit $355.3K $140.7K $126.7K
YoY Change 228.15%
Gross Profit Margin 50.26% 44.83% 49.02%
Selling, General & Admin $1.078M $577.1K $383.5K
YoY Change 45.47%
% of Gross Profit 303.33% 410.08% 302.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.17K $38.68K $38.65K
YoY Change -66.1%
% of Gross Profit 11.02% 27.48% 30.51%
Operating Expenses $1.232M $577.3K $383.6K
YoY Change 66.33%
Operating Profit -$877.1K -$436.6K -$256.9K
YoY Change 38.64%
Interest Expense -$101.9K -$84.09K -$87.87K
YoY Change 90.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$979.0K -$520.7K -$344.8K
YoY Change 42.65%
Income Tax
% Of Pretax Income
Net Earnings -$979.0K -$520.7K -$344.8K
YoY Change 42.65%
Net Earnings / Revenue -138.48% -165.86% -133.43%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.13 -$0.11 -$0.04
COMMON SHARES
Basic Shares Outstanding 7.956M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.017M $56.08K $44.71K
YoY Change 412.88%
Cash & Equivalents $2.017M $56.08K
Short-Term Investments
Other Short-Term Assets $55.37K $814.6K $671.9K
YoY Change -87.37%
Inventory $672.3K $775.7K $742.1K
Prepaid Expenses
Receivables $467.3K $296.1K $122.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.212M $1.942M $1.581M
YoY Change 84.86%
LONG-TERM ASSETS
Property, Plant & Equipment $10.57K $2.946K $424.8K
YoY Change 783.21%
Goodwill $2.238M $2.238M
YoY Change 0.0%
Intangibles $1.487M $1.525M
YoY Change -9.38%
Long-Term Investments
YoY Change
Other Assets $9.440K $9.440K $9.440K
YoY Change 0.0%
Total Long-Term Assets $4.270M $4.332M $4.236M
YoY Change -1.98%
TOTAL ASSETS
Total Short-Term Assets $3.212M $1.942M $1.581M
Total Long-Term Assets $4.270M $4.332M $4.236M
Total Assets $7.481M $6.274M $5.817M
YoY Change 22.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $176.1K $722.7K $471.0K
YoY Change -33.93%
Accrued Expenses $254.9K $894.7K $577.9K
YoY Change -17.72%
Deferred Revenue $10.40K
YoY Change
Short-Term Debt $789.3K $3.496M $3.233M
YoY Change -75.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.506M $5.226M $4.393M
YoY Change -61.87%
LONG-TERM LIABILITIES
Long-Term Debt $1.821M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $418.1K $452.6K $351.6K
YoY Change 4.91%
Total Long-Term Liabilities $2.239M $452.6K $351.6K
YoY Change 461.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.506M $5.226M $4.393M
Total Long-Term Liabilities $2.239M $452.6K $351.6K
Total Liabilities $3.745M $5.679M $4.745M
YoY Change -13.86%
SHAREHOLDERS EQUITY
Retained Earnings -$7.305M -$6.326M
YoY Change 45.42%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.736M $595.4K $1.072M
YoY Change
Total Liabilities & Shareholders Equity $7.481M $6.274M $5.817M
YoY Change 22.78%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$979.0K -$520.7K -$344.8K
YoY Change 42.65%
Depreciation, Depletion And Amortization $39.17K $38.68K $38.65K
YoY Change -66.1%
Cash From Operating Activities -$1.062M -$251.4K $74.18K
YoY Change 200.0%
INVESTING ACTIVITIES
Capital Expenditures $8.300K $1.120K $0.00
YoY Change 558.73%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$8.300K -$1.120K $0.00
YoY Change -99.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.031M 263.9K -93.59K
YoY Change 20.95%
NET CHANGE
Cash From Operating Activities -1.062M -251.4K 74.18K
Cash From Investing Activities -8.300K -1.120K 0.000
Cash From Financing Activities 3.031M 263.9K -93.59K
Net Change In Cash 1.961M 11.39K -19.41K
YoY Change 1272.54%
FREE CASH FLOW
Cash From Operating Activities -$1.062M -$251.4K $74.18K
Capital Expenditures $8.300K $1.120K $0.00
Free Cash Flow -$1.071M -$252.5K $74.18K
YoY Change 201.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42033
dei Entity Registrant Name
EntityRegistrantName
CleanCore Solutions, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-4042082
dei Entity Address Address Line1
EntityAddressAddressLine1
5920 S 118th Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Omaha
dei Entity Address Country
EntityAddressCountry
NE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
68137
dei City Area Code
CityAreaCode
(877)
dei Local Phone Number
LocalPhoneNumber
860-3030
dei Security12b Title
Security12bTitle
Class B Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ZONE
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7955919 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56082 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
393194 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296054 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
233560 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
775685 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
672116 usd
CY2024Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
773749 usd
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
302755 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40890 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
135666 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1942460 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1737291 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2946 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1197 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
556107 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
466661 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1525422 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1640919 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2237910 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2237910 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9440 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9440 usd
CY2024Q1 us-gaap Assets
Assets
6274285 usd
CY2023Q2 us-gaap Assets
Assets
6093418 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1601224 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
644627 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128749 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87985 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3225000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2994750 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5226289 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3948664 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
452564 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
398540 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5678853 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4347204 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
400 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6920756 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6768775 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6325970 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5023207 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
595432 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1746214 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6274285 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6093418 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1746214 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63960 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-437294 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1372880 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44012 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-344799 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1072093 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44009 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-520670 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
595432 usd
CY2024Q1 us-gaap Cash
Cash
56082 usd
us-gaap Net Income Loss
NetIncomeLoss
-1302763 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-485530 usd
CY2024Q2 us-gaap Investment Company Purchase Premium Per Share
InvestmentCompanyPurchasePremiumPerShare
3.72
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4
CY2024Q2 zone Underwriters Discount
UnderwritersDiscount
0.07 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
187500 shares
CY2024Q2 us-gaap Share Price
SharePrice
3.72
us-gaap Other Expenses
OtherExpenses
4239500 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s and Predecessor’s financial statements require management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure in the Company’s combined financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates. Significant estimates and assumptions made by the Company are allowance for bad debt, useful lives of fixed assets, warranty liabilities, and allowance for inventory obsolescence.</p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20585 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4419 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
19235 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
14940 usd
CY2024Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
773749 usd
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
302755 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
17737 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
2210 usd
us-gaap Advertising Expense
AdvertisingExpense
43191 usd
us-gaap Marketing Expense
MarketingExpense
12814 usd
us-gaap Advertising Expense
AdvertisingExpense
4621 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
17435 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
17435 usd
CY2024Q1 us-gaap Revenues
Revenues
313920 usd
CY2023Q1 us-gaap Revenues
Revenues
621406 usd
us-gaap Revenues
Revenues
898010 usd
us-gaap Revenues
Revenues
1470175 usd
us-gaap Revenues
Revenues
502990 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
316639 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
237979 usd
CY2024Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
20585 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
4419 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296054 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
233560 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
525093 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
551264 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
269827 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
135792 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
19235 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
14940 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
775685 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
672116 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
19235 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
14940 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
722734 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
266511 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
376467 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
152684 usd
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
313910 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
68026 usd
CY2024Q1 zone Accrued Warranty Reserve
AccruedWarrantyReserve
112559 usd
CY2023Q2 zone Accrued Warranty Reserve
AccruedWarrantyReserve
156333 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75554 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1073 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1601224 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
644627 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3000000 usd
us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
355726 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
271316 usd
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
221302 usd
CY2022Q4 us-gaap Debt Instrument Issued Principal
DebtInstrumentIssuedPrincipal
104450 usd
CY2024Q1 us-gaap Debt Instrument Issued Principal
DebtInstrumentIssuedPrincipal
500000 usd
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.08 pure
CY2024Q1 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.13 pure
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2024Q1 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.25
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.74
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29999 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3240000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.74
CY2022Q4 zone Aggregate Exercise Price Of The Parent
AggregateExercisePriceOfTheParent
500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0371 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5305 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.34
CY2023 zone Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grant In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantInPeriod
824041 shares
CY2023 zone Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P0Y5M8D
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.69
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2770000 shares
CY2023 zone Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted1
P4Y9M7D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.51
CY2023 zone Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
777778 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.61
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2125152 shares
CY2023Q2 zone Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsOutstanding
46263 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2770000 shares
CY2023 zone Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P5Y3D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.59
zone Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
46263 shares
zone Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Canceled
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermCanceled
P0Y2M26D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2463889 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2770000 shares
zone Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P4Y9M7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
855556 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
187973 usd
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1512 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
90307 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
90307 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0656 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
40450 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
163147 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
167226 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
171407 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
116160 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
658390 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
77077 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
581313 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128749 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
452564 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2024Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q2 zone Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsOutstanding
shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001956741

Files In Submission

Name View Source Status
0001213900-24-051214-index-headers.html Edgar Link pending
0001213900-24-051214-index.html Edgar Link pending
0001213900-24-051214.txt Edgar Link pending
0001213900-24-051214-xbrl.zip Edgar Link pending
ea0207376-10q_cleancore.htm Edgar Link pending
ea020737601ex31-1_cleancore.htm Edgar Link pending
ea020737601ex31-2_cleancore.htm Edgar Link pending
ea020737601ex32-1_cleancore.htm Edgar Link pending
ea020737601ex32-2_cleancore.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
ea0207376-10q_cleancore_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zone-20240331.xsd Edgar Link pending
zone-20240331_def.xml Edgar Link unprocessable
zone-20240331_lab.xml Edgar Link unprocessable
zone-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
zone-20240331_cal.xml Edgar Link unprocessable